{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:56:53Z","timestamp":1793239013913,"version":"4.5.0"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.phrs.2014.10.009","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T16:34:24Z","timestamp":1415637264000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":300,"special_numbering":"C","title":["Tranilast: A review of its therapeutic applications"],"prefix":"10.1016","volume":"91","author":[{"given":"Sara","family":"Darakhshan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Bidmeshki","family":"Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2014.10.009_bib0005","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0091-6749(76)90054-3","article-title":"Inhibition of hypersensitivity reactions by a new drug, N(3\u2032,4\u2032-dimethoxycinnamoyl) anthranilic acid (N-5\u2032)","volume":"57","author":"Koda","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1476-5381.1976.tb08614.x","article-title":"Pharmacological properties of N-(3\u2032,4\u2032-dimethoxycinnamoyl) anthranilic acid (N-5), a new anti-atopic agent","volume":"58","author":"Azuma","year":"1976","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1398-9995.1979.tb01701.x","article-title":"A double-blind controlled trial of N-(3\u2032,4\u2032-dimethoxycinnamoyl) anthranilic acid on children with bronchial asthma, N-5\u2032 Study Group in Children","volume":"34","author":"Shioda","year":"1979","journal-title":"Allergy"},{"key":"10.1016\/j.phrs.2014.10.009_bib0020","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0006-2952(87)90353-4","article-title":"Selective inhibition of collagen accumulation by N-(3,4-dimethoxycinnamoy1) anthranilic acid (N-5\u2032) in granulation tissue","volume":"36","author":"Isaji","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0025","first-page":"141","article-title":"Tranilast Kissei Pharmaceutical","volume":"1","author":"Konneh","year":"1998","journal-title":"Idrugs"},{"key":"10.1016\/j.phrs.2014.10.009_bib0035","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1117634","article-title":"Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite","volume":"310","author":"Platten","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.phrs.2014.10.009_bib0040","first-page":"429","article-title":"Long-term clinical study of tranilast ophthalmic solution on vernal conjunctivitis","volume":"9","author":"Kogure","year":"1993","journal-title":"J Clin Ther Med"},{"key":"10.1016\/j.phrs.2014.10.009_bib0045","first-page":"69","article-title":"Studies on the metabolic fate of tranilast in rats and mice","volume":"25","author":"Goto","year":"1991","journal-title":"J Clin Rep"},{"key":"10.1016\/j.phrs.2014.10.009_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1527-3466.1998.tb00359.x","article-title":"A new application in the cardiovascular field as an antiproliferative drug","volume":"16","author":"Isaji","year":"1998","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.phrs.2014.10.009_bib0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0021-9150(98)00308-6","article-title":"Tranilast inhibits the proliferation of human coronary smooth muscle cell through the activation of p21wafl","volume":"143","author":"Kusama","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2014.10.009_bib0060","series-title":"Japanese Orange Books No. 12 (Approved drug products with therapeutic equivalence evaluations)","first-page":"171","article-title":"Tranilast","author":"The Society of Japanese Pharmacopoeia","year":"2002"},{"key":"10.1016\/j.phrs.2014.10.009_bib0065","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jps.2600810820","article-title":"Prominent inclusion effect of dimethyl-beta-cyclodextrin on photoisomerization of the thromboxane synthetase inhibitor (E)-4-(1-imidazoylmethyl)cinnamic acid","volume":"81","author":"Hirayama","year":"1992","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0070","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1248\/cpb.33.3738","article-title":"Hyaluronidase-inhibitory and anti-allergic activities of the photo-irradiated products of tranilast","volume":"33","author":"Kakegawa","year":"1985","journal-title":"Chem Pharm Bull"},{"key":"10.1016\/j.phrs.2014.10.009_bib0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1254\/jjp.46.43","article-title":"Study of the mechanism of inhibitory action of tranilast on chemical mediator release","volume":"46","author":"Komatsu","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0080","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0006-2952(97)00187-1","article-title":"Suppressive effects of tranilast on the expression of inducible cyclooxygenase (COX2) in interleukin-1beta-stimulated fibroblasts","volume":"53","author":"Inoue","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0085","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.bjp.0704373","article-title":"N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) suppresses microglial inducible nitric oxide synthase (iNOS) expression and activity induced by interferon-gamma (IFN-gamma)","volume":"134","author":"Platten","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.bbrc.2008.04.054","article-title":"Tranilast, an orally active anti-allergic drug, up-regulates the anti-inflammatory heme oxygenase-1 expression but down-regulates the pro-inflammatory cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW264.7 macrophages","volume":"371","author":"Pae","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2014.10.009_bib0095","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/mol.62.4.856","article-title":"Tranilast inhibits cytokine-induced nuclear factor kappaB activation in vascular endothelial cells","volume":"62","author":"Spiecker","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0100","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0022-3565(24)39006-8","article-title":"Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis","volume":"295","author":"Capper","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2014.10.009_bib0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0192-0561(00)00013-8","article-title":"Inhibition of interleukin 5 production with no influence on interleukin 4 production by an anti-allergic drug, tranilast, in Toxocara canis-infected mice","volume":"22","author":"Hiratochi","year":"2000","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02713680701817366","article-title":"Suppressive effects of tranilast on eotaxin-1 production from cultured conjunctival fibroblasts","volume":"33","author":"Hida","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(01)01215-8","article-title":"Tranilast inhibits interleukin-1beta-induced monocyte chemoattractant protein-1 expression in rat mesangial cells","volume":"427","author":"Chikaraishi","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0120","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1167\/iovs.09-4161","article-title":"Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCAM-1 in human corneal fibroblasts","volume":"51","author":"Adachi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0923-1811(00)00094-3","article-title":"Inhibitory influences of tranilast on multinucleated giant cell formation from monocytes by supernatant of concanavalin A-stimulated mononuclear cells","volume":"24","author":"Mizuno","year":"2000","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1254\/jjp.60.85","article-title":"Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes\u2013macrophages","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1096\/fj.00-0273com","article-title":"Activation of paracrine TGF\u03b21 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function of chymase","volume":"15","author":"Lindstedt","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1155\/MI.2005.150","article-title":"Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro","volume":"14","author":"Shimizu","year":"2005","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.phrs.2014.10.009_bib0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1211\/jpp.58.1.0011","article-title":"Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro","volume":"58","author":"Shimizu","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0150","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0192-0561(93)90063-5","article-title":"Cell action mechanism of tranilast \u2013 effect on the expression of HLA-class II antigen","volume":"15","author":"Kawano","year":"1993","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1248\/bpb1978.10.255","article-title":"The effect of tranilast on the generation of reactive oxygen species","volume":"10","author":"Miyachi","year":"1987","journal-title":"J Pharmacobiodyn"},{"key":"10.1016\/j.phrs.2014.10.009_bib0160","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/labinvest.3700669","article-title":"Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations","volume":"87","author":"Prud\u2019homme","year":"2007","journal-title":"Lab Invest"},{"key":"10.1016\/j.phrs.2014.10.009_bib0165","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/0006-2952(89)90553-4","article-title":"Inhibitory effect of tranilast on prostaglandin D synthetase","volume":"38","author":"Ikai","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0170","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1016\/S0021-9258(18)61429-2","article-title":"Biochemical and immunological characterization of rat spleen prostaglandin D synthetase","volume":"262","author":"Urade","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2014.10.009_bib0175","doi-asserted-by":"crossref","first-page":"12410","DOI":"10.1016\/S0021-9258(17)38889-0","article-title":"Purification and characterization of rat brain prostaglandin D synthetase","volume":"260","author":"Urade","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2014.10.009_bib0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1440-1827.2009.02490.x","article-title":"Rectal administration of tranilast ameliorated acute colitis in mice through increased expression of heme oxygenase-1","volume":"60","author":"Sun","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.phrs.2014.10.009_bib0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/imm.12026","article-title":"Suppression of the allogeneic response by the anti-allergy drug N-(3,4-dimethoxycinnamonyl) anthranilic acid results from T-cell cycle arrest","volume":"138","author":"Zaher","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2014.10.009_bib0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cbf.1805","article-title":"Novel action of 3,4-DAA ameliorating acute liver allograft injury","volume":"29","author":"Sun","year":"2011","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.phrs.2014.10.009_bib0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2014.01.055","article-title":"Combination of N-(3\u2032,4\u2032-dimethoxycinnamoyl) anthranilic acid with cyclosporin A treatment preserves immunosuppressive effect and reduces the side effect of cyclosporin A in rat","volume":"728","author":"Yong-Gang","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0200","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/rheumatology\/kem160","article-title":"The anti-allergic drug, N-(3\u2032,4\u2032-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis","volume":"46","author":"Inglis","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2014.10.009_bib0205","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.transproceed.2011.01.160","article-title":"Tranilast prevents the progression of chronic cyclosporine nephrotoxicity through regulation of transforming growth factor \u03b2\/Smad pathways","volume":"43","author":"Tao","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.phrs.2014.10.009_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1254\/jphs.FP0070534","article-title":"Tranilast suppresses the disease development of the adjuvant- and streptococcal cell wall-induced arthritis in rats","volume":"105","author":"Nagate","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0215","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1476-5381.2009.00561.x","article-title":"The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice","volume":"159","author":"Shiota","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0220","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bcp.2011.06.013","article-title":"Suppression of human CD4+ T cell activation by 3,4-dimethoxycinnamonylanthranilic acid (tranilast) is mediated by CXCL9 and CXCL10","volume":"82","author":"Hertenstein","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3899\/jrheum.090769","article-title":"CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis","volume":"37","author":"Kuan","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0230","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0091-6749(92)90444-7","article-title":"Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells","volume":"89","author":"Bentley","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0235","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00004872-200405000-00006","article-title":"Tranilast and hypertensive heart disease: further insights into mechanisms of an anti-inflammatory and anti-fibrotic drug","volume":"22","author":"Pfab","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.phrs.2014.10.009_bib0240","first-page":"88","article-title":"The effects of long term tranilast administration on bronchial hypersensitivity in asthmatics","volume":"31","author":"Suzuki","year":"1989","journal-title":"Panminerva Med"},{"key":"10.1016\/j.phrs.2014.10.009_bib0245","first-page":"1334","article-title":"The investigation of asthmatic children by multiple factor analysis. III. The changes in allergic factors selected by multiple factor analysis in 3 anti-allergic during treated groups over one year","volume":"38","author":"Koya","year":"1989","journal-title":"Arerugi"},{"key":"10.1016\/j.phrs.2014.10.009_bib0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1254\/jjp.86.130","article-title":"Suppressive effect of tranilast on interleukin-5 prolonged eosinophils survival via apoptosis","volume":"86","author":"Cheng","year":"2001","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2222.1996.tb01137.x","article-title":"The prolonged survival of human eosinophils with interleukin-5 and its inhibition by the theophylline via apoptosis","volume":"26","author":"Ohta","year":"1996","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.phrs.2014.10.009_bib0260","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2222.1992.tb00146.x","article-title":"Inhibition of proliferative responses of lymphocytes to food antigens by an anti-allergic drug, N(3\u2032,4\u2032-dimethoxycinnamoyl) anthranilic acid (tranilast) in children with atopic dermatitis","volume":"22","author":"Kondo","year":"1992","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.phrs.2014.10.009_bib0265","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0385-8146(12)80119-2","article-title":"Clinical and pathophysiological evaluation of tranilast in patients with pollenosis: the effects of pre-seasonal treatment","volume":"20","author":"Ukai","year":"1993","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.phrs.2014.10.009_bib0270","first-page":"895","article-title":"Tranilast (N-(3,4-dimethoxycinnamoyl) anthranilic acid) down-regulates the growth inhibition between gastric cancer cells and fibroblasts","volume":"17","author":"Yashiro","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0275","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00003226-200005000-00021","article-title":"Inhibitory effects of tranilast on the proliferation and function of human pterygium-derived fibroblasts","volume":"19","author":"Isaji","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.phrs.2014.10.009_bib0280","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000063884","article-title":"Effect of tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts","volume":"34","author":"Yasukawa","year":"2002","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0285","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejphar.2004.07.061","article-title":"Inhibition by tranilast of nifedipine-induced proliferation of cultured human gingival fibroblasts","volume":"498","author":"Hattori","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0290","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1368-8375(02)00092-1","article-title":"Effects of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma","volume":"39","author":"Noguchi","year":"2003","journal-title":"Oral Oncol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0295","doi-asserted-by":"crossref","first-page":"PL287","DOI":"10.1016\/0024-3205(94)00668-7","article-title":"Inhibition by tranilast of collagen accumulation in hypersensitive granulomatous inflammation in vivo and of morphological changes and functions of fibroblasts in vitro","volume":"55","author":"Isaji","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0300","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1254\/jjp.60.91","article-title":"The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts","volume":"60","author":"Suzawa","year":"1992","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0305","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1006\/bbrc.1996.1508","article-title":"Inhibitory effect of tranilast on activation and transforming growth factor beta 1 expression in cultured rat stellate cells","volume":"227","author":"Ikeda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.phrs.2014.10.009_bib0310","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/hep.22338","article-title":"Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis","volume":"48","author":"Uno","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2014.10.009_bib0315","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1254\/jjp.67.279","article-title":"Suppressive effects of tranilast on pulmonary fibrosis and activation of alveolar macrophages in mice treated with bleomycin: role of alveolar macrophages in the fibrosis","volume":"67","author":"Mori","year":"1995","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0320","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.bcp.2005.05.034","article-title":"Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells","volume":"70","author":"Iwata","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0325","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00004872-200405000-00024","article-title":"Tranilast attenuates myocardial fibrosis in association with suppression of monocyte\/macrophage infiltration in DOCA\/salt hypertensive rats","volume":"22","author":"Kagitani","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.phrs.2014.10.009_bib0330","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.HYP.36.5.747","article-title":"Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 rat","volume":"36","author":"Pinto","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2014.10.009_bib0335","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2230.1994.tb02689.x","article-title":"Treatment of linear localized scleroderma with the anti-allergic drug, tranilast","volume":"19","author":"Taniguchi","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0340","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/oxfordjournals.jbchem.a124612","article-title":"Tranilast a selective inhibitor of collagen synthesis in human skin fibroblasts","volume":"116","author":"Yamada","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/j.phrs.2014.10.009_bib0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jdiacomp.2004.02.002","article-title":"Tranilast reduces mesenteric vascular collagen deposition and chymase-positive mast cells in experimental diabetes","volume":"18","author":"Jones","year":"2004","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.phrs.2014.10.009_bib0350","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1072-7515(97)00059-8","article-title":"Factors affecting hypertrophic scar development in median sternotomy incisions for congenital cardiac surgery","volume":"185","author":"Nakamura","year":"1997","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.phrs.2014.10.009_bib0355","first-page":"3045","article-title":"Clinical evaluation of tranilast for keloid and hypertrophic scarring. Optimal dose finding study in a double blind study","volume":"18","author":"Nanba","year":"1992","journal-title":"Nessho"},{"key":"10.1016\/j.phrs.2014.10.009_bib0360","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0923-1811(94)00355-I","article-title":"Tranilast inhibits collagen synthesis in normal, scleroderma and keloid fibroblasts at a late passage culture but not at an early passage culture","volume":"9","author":"Yamada","year":"1995","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0021-9150(97)00275-X","article-title":"Inhibitory effects of tranilast on expression of transforming growth factor-beta isoforms and receptors in injured arteries","volume":"137","author":"Ward","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2014.10.009_bib0370","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.ki.5000189","article-title":"Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells","volume":"69","author":"Qi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.phrs.2014.10.009_bib0375","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1076\/0271-3683(200004)2041-5FT283","article-title":"Tranilast inhibits cell proliferation and collagen synthesis by rabbit corneal and Tenon's capsule fibroblasts","volume":"20","author":"Oshima","year":"2000","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0380","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0701493","article-title":"Tranilast inhibits the proliferation, chemotaxis, and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo","volume":"322","author":"Isaji","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0385","first-page":"617","article-title":"Tranilast inhibits smooth muscle cell proliferation by induction of c-myc and c-fos proto-oncogenes","volume":"94","author":"Taniguchi","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2014.10.009_bib0390","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(95)05607-6","article-title":"Inhibition of PDGF- and TGF\u03b2-induced collagen synthesis, migration, and proliferation by tranilast in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"18","author":"Miyazawa","year":"1995","journal-title":"Arherosclerosis"},{"key":"10.1016\/j.phrs.2014.10.009_bib0395","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0014-2999(97)00080-0","article-title":"Tranilast inhibits the growth of rat mesangial cells","volume":"324","author":"Ikeda","year":"1997","journal-title":"Eur J Phannacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0400","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1161\/01.ATV.0000026614.72957.E7","article-title":"Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway","volume":"22","author":"Sata","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0405","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1272\/jnms.69.224","article-title":"Antitumor effect of N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) on experimental pancreatic cancer","volume":"69","author":"Hiroi","year":"2002","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.phrs.2014.10.009_bib0410","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1210\/jc.2002-020444","article-title":"Tranilast inhibits the proliferation of uterine leiomyoma cells in vitro through G1 arrest associated with the induction of p21(waf1) and p53","volume":"87","author":"Shime","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.phrs.2014.10.009_bib0415","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ijc.1289","article-title":"N-[3,4-Dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta release and reduces migration and invasiveness of human malignant glioma cells","volume":"93","author":"Platten","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.phrs.2014.10.009_bib0420","first-page":"3899","article-title":"Tranilast (N-3,4-dimethoxycinamoyl anthranilic acid): a novel inhibitor of invasion-stimulating interaction between gastric cancer cells and orthotopic fibroblasts","volume":"23","author":"Yashiro","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0425","first-page":"85","article-title":"Sensitivity of scirrhous gastric cancer to 5-fluorouracil and the role of cancer cell-stromal fibroblast interaction","volume":"12","author":"Nakajima","year":"2004","journal-title":"Oncol Rep"},{"key":"10.1016\/j.phrs.2014.10.009_bib0430","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/pros.20975","article-title":"Tranilast inhibits hormone-refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes","volume":"69","author":"Izumi","year":"2009","journal-title":"Prostate"},{"key":"10.1016\/j.phrs.2014.10.009_bib0435","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0143-4160(97)90107-X","article-title":"Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca(2+)-permeable channel","volume":"22","author":"Nie","year":"1997","journal-title":"Cell Calcium"},{"key":"10.1016\/j.phrs.2014.10.009_bib0440","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/CAD.0b013e328327994e","article-title":"Tranilast inhibits the growth and metastasis of mammary carcinoma","volume":"20","author":"Chakrabarti","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phrs.2014.10.009_bib0445","article-title":"Tamoxifen and tranilast show a synergistic effect against breast cancer in vitro","author":"Darakhshan","year":"2013","journal-title":"Bratislava Med J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0450","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1620\/tjem.217.193","article-title":"Tranilast, an anti-allergic drug, down-regulates the growth of cultured neurofibroma cells derived from neurofibromatosis type 1","volume":"217","author":"Yamamoto","year":"2009","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.phrs.2014.10.009_bib0455","first-page":"1151","article-title":"Antiangiogenic and antitumor effects of tranilast on mouse lung carcinoma cells","volume":"17","author":"Yatsunami","year":"2000","journal-title":"Int J Oncol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0460","first-page":"3077","article-title":"Preliminary results of tranilast treatment for patients with advanced castration resistant prostate cancer","volume":"30","author":"Izumi","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0465","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/pros.21056","article-title":"Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro","volume":"70","author":"Sato","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.phrs.2014.10.009_bib0470","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.fertnstert.2014.05.013","article-title":"Tranilast, an orally active antiallergic compound, inhibits extracellular matrix production in human uterine leiomyoma and myometrial cells","volume":"102","author":"Islam","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.phrs.2014.10.009_bib0475","first-page":"341","article-title":"Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1","volume":"36","author":"Mitsuno","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0480","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1158\/1078-0432.CCR-07-1656","article-title":"Effect of trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer","volume":"15","author":"Fan","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0485","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yexmp.2010.10.012","article-title":"Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells","volume":"90","author":"Subramaniam","year":"2011","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0490","doi-asserted-by":"crossref","first-page":"e13831","DOI":"10.1371\/journal.pone.0013831","article-title":"Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist","volume":"5","author":"Prud\u2019homme","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phrs.2014.10.009_bib0495","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1423-0127-20-76","article-title":"Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro","volume":"20","author":"Darakhshan","year":"2013","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0500","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/1752-1947-4-384","article-title":"Successful treatment of desmoid tumor of the chest wall with tranilast: a case report","volume":"4","author":"Goto","year":"2010","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.phrs.2014.10.009_bib0505","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2174\/138161212800626120","article-title":"Cancer stem cells and novel targets for antitumor strategies","volume":"18","author":"Prud\u2019homme","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.phrs.2014.10.009_bib0510","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-007-9798-y","article-title":"NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells","volume":"111","author":"Zhou","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.phrs.2014.10.009_bib0515","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature10525","article-title":"A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours","volume":"478","author":"Beck","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2014.10.009_bib0520","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pharmthera.2009.09.004","article-title":"The pleiotropy of dioxin toxicity \u2013 xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles","volume":"124","author":"Furness","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.phrs.2014.10.009_bib0525","series-title":"Vascular brachytherapy","first-page":"3","article-title":"Restenosis following angioplasty: scope of the problem","author":"King","year":"1999"},{"key":"10.1016\/j.phrs.2014.10.009_bib0530","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0002-8703(99)70025-6","article-title":"Impact of tranilast on restenosis after coronary angioplasty: Tranilast Restenosis Following Angioplasty Trial (TREAT)","volume":"138","author":"Tamai","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0535","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1067\/mhj.2002.120770","article-title":"The impact of tranilast on restenosis after coronary angioplasty: the second Tranilast Restenosis Following Angioplasty Trial (TREAT-2)","volume":"143","author":"Tamai","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0540","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2014.10.009_bib0545","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0002-8703(00)90304-1","article-title":"The PRESTO (Prevention of REstenosis with Tranilast and its Outcomes) protocol: a doubleblind, placebo-controlled trial","volume":"139","author":"Holmes","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0550","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0002-8703(97)70055-3","article-title":"Effectiveness of tranilast on restenosis after directional coronary atherectomy","volume":"134","author":"Kosuga","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0555","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(95)00636-2","article-title":"Tranilast suppresses intimal hyperplasia after photochemically induced endothelial injury in the rat","volume":"295","author":"Kikuchi","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0560","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0735-1097(00)00528-3","article-title":"Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation","volume":"35","author":"Ishiwata","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0565","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.ATV.18.7.1069","article-title":"Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening","volume":"18","author":"Kikuchi","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0570","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0021-9150(96)06053-4","article-title":"Tranilast inhibits contraction and Ca2+ movement of porcine coronary arteries","volume":"130","author":"Ishibashi","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2014.10.009_bib0575","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0026-895X(25)09376-9","article-title":"Blockage of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells","volume":"50","author":"Nie","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0580","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1139\/y95-230","article-title":"Inhibitory effects of tranilast on proliferation, migration and collagen synthesis of human vascular smooth muscle cells","volume":"74","author":"Fukuyama","year":"1996","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0585","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0021-9150(95)05709-9","article-title":"Tranilast antagonizes angiotensin II and inhibits its biological effects in vascular smooth muscle cells","volume":"121","author":"Miyazawa","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phrs.2014.10.009_bib0590","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000074845","article-title":"Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy","volume":"95","author":"Mifsud","year":"2003","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0595","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1152\/ajpheart.01167.2006","article-title":"Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy","volume":"293","author":"Kelly","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0600","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(01)01501-1","article-title":"Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation","volume":"21","author":"Saiura","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0605","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.99.7.919","article-title":"Suppression of atherosclerotic development in Watanabe heritable hyperlipidemic rabbits treated with an oral antiallergic drug, tranilast","volume":"99","author":"Matsumura","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2014.10.009_bib0610","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1254\/jjp.78.161","article-title":"Inhibitory effect of tranilast on hypertrophic collagen production in the spontaneously hypertensive rat heart","volume":"78","author":"Umemura","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0615","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.20002036","article-title":"Evidence for a role of mast cells in the evolution to congestive heart failure","volume":"195","author":"Hara","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.phrs.2014.10.009_bib0620","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1161\/hq0701.092119","article-title":"Tranilast inhibits cardiac allograft vasculopathy in association with p21(Waf1\/Cip1) expression on neointimal cells in murine cardiac transplantation model","volume":"21","author":"Izawa","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0625","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1161\/01.CIR.99.8.1084","article-title":"Tranilast suppresses vascular chymase expression and neointima formation in balloon-injured dog carotid artery","volume":"99","author":"Shiota","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2014.10.009_bib0630","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2012.11.014","article-title":"Tranilast prevents atrial remodeling and development of atrial fibrillation in a canine model of atrial tachycardia and left ventricular dysfunction","volume":"61","author":"Nakatani","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0635","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-2999(98)00740-7","article-title":"Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II","volume":"361","author":"Jin","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0640","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bjp.0702564","article-title":"Tranilast inhibits protein kinase C-dependent signaling pathway linked to angiogenic activities and gene expression of retinal microcapillary endothelial cells","volume":"127","author":"Koyama","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0645","first-page":"459","article-title":"Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat","volume":"40","author":"Takehana","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0650","doi-asserted-by":"crossref","first-page":"PL71","DOI":"10.1016\/S0024-3205(98)00277-X","article-title":"Inhibition by tranilast of vascular endothelial growth factor (VEGF)\/vascular permeability factor (VPF)-induced increase in vascular permeability in rats","volume":"63","author":"Isaji","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0655","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.7314\/APJCP.2013.14.11.6869","article-title":"Synergistic effects of tamoxifen and tranilast on VEGF and MMP-9 regulation in cultured human breast cancer cells","volume":"14","author":"Darakhshan","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.phrs.2014.10.009_bib0660","unstructured":"http:\/\/ClinicalTrials.gov Identifier: NCT00882024."},{"key":"10.1016\/j.phrs.2014.10.009_bib0665","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s004170050298","article-title":"The effect of tranilast on experimental proliferative vitreoretinopathy","volume":"237","author":"Ito","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0670","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00061198-200204000-00008","article-title":"Effects of tranilast on filtering blebs: a pilot study","volume":"11","author":"Chihara","year":"2002","journal-title":"J Glaucoma"},{"key":"10.1016\/j.phrs.2014.10.009_bib0675","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jcrs.2004.09.056","article-title":"Effects of topical tranilast on corneal haze after photorefractive keratectomy","volume":"31","author":"Song","year":"2005","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.phrs.2014.10.009_bib0680","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0021-5155(99)00103-3","article-title":"Effects of tranilast on cultured rabbit corneal keratocytes and corneal haze after photorefractive keratectomy","volume":"43","author":"Okamoto","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0685","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0021-5155(02)00541-5","article-title":"Effects of various eye drops on corneal wound healing after superficial keratectomy in rabbits","volume":"46","author":"Tani","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0690","first-page":"203","article-title":"Tranilast inhibits TGF-\u03b21 secretion without affecting its mRNA levels in conjunctival cells","volume":"47","author":"Ochiai","year":"2001","journal-title":"Kobe J Med Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0695","first-page":"120","article-title":"A case in which tranilast ophthalmic solution was thought to be effective for the prevention of symblepharon and recurrence after pterygium surgery","volume":"36","author":"Tsuji","year":"2011","journal-title":"Tokai J Exp Clin Med"},{"key":"10.1016\/j.phrs.2014.10.009_bib0700","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0886-3350(99)00211-4","article-title":"Effect of tranilast eyedrops in preventing posterior capsule opacification: preliminary report","volume":"25","author":"Tobari","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.phrs.2014.10.009_bib0710","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1389450033490920","article-title":"Insulin resistance as a proinflammatory state: mechanisms, mediators, and therapeutic interventions","volume":"4","author":"Garg","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.phrs.2014.10.009_bib0715","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.mehy.2003.11.047","article-title":"Tranilast: a novel weapon against insulin resistance","volume":"64","author":"Namazi","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.phrs.2014.10.009_bib0720","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11892-006-0083-y","article-title":"Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history","volume":"6","author":"Rossing","year":"2006","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.phrs.2014.10.009_bib0725","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000064071","article-title":"Tranilast slows the progression of advanced diabetic nephropathy","volume":"92","author":"Soma","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.phrs.2014.10.009_bib0730","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/ndt\/gfl325","article-title":"Effect of tranilast in early-stage diabetic nephropathy","volume":"21","author":"Soma","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.phrs.2014.10.009_bib0735","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1124\/jpet.105.084772","article-title":"Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression","volume":"314","author":"Akahori","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.phrs.2014.10.009_bib0740","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: the Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2014.10.009_bib0745","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/ndt\/gfq355","article-title":"Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy","volume":"26","author":"Tan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.phrs.2014.10.009_bib0750","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1262-3636(07)70049-6","article-title":"Tranilast attenuates vascular hypertrophy, matrix accumulation and growth factor overexpression in experimental diabetes","volume":"29","author":"Bonnet","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.phrs.2014.10.009_bib0755","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1254\/jphs.13151FP","article-title":"Tranilast alleviates endothelial dysfunctions and insulin resistance via preserving glutathione peroxidase 1 in rats fed a high-fat emulsion","volume":"124","author":"Yang","year":"2014","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0760","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-2008-1073163","article-title":"Tranilast inhibits glucose-induced insulin secretion from pancreatic beta-cells","volume":"40","author":"Taguchi","year":"2008","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0765","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/db08-0862","article-title":"Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells","volume":"58","author":"Hisanaga","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2014.10.009_bib0770","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0022-5347(05)66400-2","article-title":"Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction","volume":"165","author":"Miyajima","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0775","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0922-4106(95)90087-X","article-title":"Tranilast inhibits the effects of platelet-derived growth factor on cell proliferation and induction of nitric oxide","volume":"291","author":"Hishikawa","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0780","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1248\/bpb.33.1710","article-title":"Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-\u03b21 production","volume":"33","author":"Saegusa","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.phrs.2014.10.009_bib0785","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1097\/01.ASN.0000139066.77892.04","article-title":"Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model","volume":"15","author":"Kelly","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0790","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1016\/j.transproceed.2009.09.073","article-title":"Tranilast attenuates chronic cyclosporine nephrotoxicity in rats","volume":"41","author":"Tao","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.phrs.2014.10.009_bib0795","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/00313025.2010.508784","article-title":"Tranilast modulates fibrosis, epithelial-mesenchymal transition and peritubular capillary injury in unilateral ureteral obstruction rats","volume":"42","author":"Kaneyama","year":"2010","journal-title":"Pathology"},{"key":"10.1016\/j.phrs.2014.10.009_bib0800","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/00007890-200110150-00015","article-title":"Cyclosporine and long-term kidney graft survival","volume":"72","author":"Opelz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2014.10.009_bib0805","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.ki.5000376","article-title":"Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model","volume":"69","author":"Kelly","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.phrs.2014.10.009_bib0810","first-page":"536","article-title":"Cyclosporine nephropathy: pathophysiology and clinical impact","volume":"16","author":"Shihab","year":"1996","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0815","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ki.1988.38","article-title":"The long-term course of cyclosporine-associated chronic nephropathy","volume":"33","author":"Myers","year":"1988","journal-title":"Kidney Int"},{"key":"10.1016\/j.phrs.2014.10.009_bib0820","first-page":"1235","article-title":"Tranilast and cisplatin as an experimental combination therapy for scirrhous gastric cancer","volume":"13","author":"Murahashi","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0825","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1677\/erc.1.01112","article-title":"The pleiotropic roles of transforming growth factor beta in homeostasis and carcinogenesis of endocrine organs","volume":"13","author":"Fleisch","year":"2006","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.phrs.2014.10.009_bib0830","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)00121-5","article-title":"TGFbeta signaling in growth control, cancer, and heritable disorders","volume":"103","author":"Massague","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2014.10.009_bib0835","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massague","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.phrs.2014.10.009_bib0840","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0845","first-page":"3151","article-title":"Transforming growth factor-B, Smads, and cancer","volume":"9","author":"Grady","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0850","first-page":"409","article-title":"Inhibitory effect of an antiallergic drug, tranilast, on the production of cytokines","volume":"43","author":"Suzawa","year":"1992","journal-title":"Pharmacokinetics"},{"key":"10.1016\/j.phrs.2014.10.009_bib0855","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00000637-199943020-00013","article-title":"Expression of transforming growth factor beta 1, 2, 3 proteins in keloids","volume":"43","author":"Lee","year":"1999","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.phrs.2014.10.009_bib0860","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardiores.2004.10.041","article-title":"Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta","volume":"65","author":"Martin","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0865","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/10408360490460933","article-title":"Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation","volume":"41","author":"Hyytiainen","year":"2004","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0870","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-230X-3-29","article-title":"Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats","volume":"3","author":"Arias","year":"2003","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0875","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.phrs.2014.10.009_bib0880","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1007\/s00018-006-6085-8","article-title":"Role of transforming growth factor-beta in the progression of heart failure","volume":"63","author":"Lim","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0885","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.ATV.0000019405.84384.9C","article-title":"Tranilast prevents activation of transforming growth factor-\u03b2 system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting","volume":"22","author":"Ward","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0890","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/01.RES.84.5.543","article-title":"Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21 (waf1\/cip1\/sdi1) and p53","volume":"84","author":"Takahashi","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0895","first-page":"683","article-title":"The effects of tamoxifen in combination with tranilast on CXCL12-CXCR4 axis and invasion in breast cancer cell lines","volume":"12","author":"Darakhshan","year":"2014","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0900","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0006-2952(03)00449-0","article-title":"Involvement of protein kinase Cdelta and extracellular signal-regulated kinase-2 in the suppression of microglial inducible nitric oxide synthase expression by N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast)","volume":"66","author":"Platten","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0905","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bjp.0703285","article-title":"Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors","volume":"130","author":"Watanabe","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0910","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2014.10.009_bib0915","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1677\/ERC-09-0054","article-title":"The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy","volume":"16","author":"Zhang","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.phrs.2014.10.009_bib0920","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-3-642-54215-2_10","article-title":"TRPV2","volume":"222","author":"Kojima","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0925","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ni.1842","article-title":"TRPV2 has a pivotal role in macrophage particle binding and phagocytosis","volume":"11","author":"Link","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0930","doi-asserted-by":"crossref","first-page":"113","DOI":"10.33549\/physiolres.932053","article-title":"Mast-cell degranulation induced by physical stimuli involves the activation of transient-receptor-potential channel TRPV2","volume":"61","author":"Zhang","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0935","first-page":"34","article-title":"The role of transient receptor potential vanilloid type-2 ion channels in innate and adaptive immune responses","volume":"14","author":"Santoni","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0940","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/hmg\/ddn408","article-title":"Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models","volume":"18","author":"Iwata","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.phrs.2014.10.009_bib0945","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/cvr\/cvt163","article-title":"Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy","volume":"99","author":"Iwata","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0950","first-page":"178","article-title":"A clinical evaluation of N-5\u2032 with perennial-type allergic rhinitis \u2013 a test by the multi-clinic, intergroup, double-blind comparative method","volume":"53","author":"Okuda","year":"1984","journal-title":"Ann Allergy"},{"key":"10.1016\/j.phrs.2014.10.009_bib0955","first-page":"2471","article-title":"Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders","volume":"32","author":"Rogosnitzky","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.phrs.2014.10.009_bib0960","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.lfs.2013.10.010","article-title":"High-dose tranilast administration to rats creates interstitial cystitis-like symptoms with increased vascular permeability","volume":"93","author":"Nishijima","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.phrs.2014.10.009_bib0965","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/sj.tpj.6500221","article-title":"A Gilbert's syndrome UGT1A1 variant confers susceptibility to tranilast-induced hyperbilirubinemia","volume":"4","author":"Danoff","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.phrs.2014.10.009_bib0970","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/j.1346-8138.1998.tb02488.x","article-title":"Immune thrombocytopenia due to tranilast (Rizaben): detection of drug-dependent platelet-associated IgG","volume":"25","author":"Nagae","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0975","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1365-2133.2005.06940.x","article-title":"Vulval syringoma successfully treated with tranilast","volume":"153","author":"Iwao","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0980","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1346-8138.2012.01612.x","article-title":"Efficacy of N-(3,4-dimethoxycinnamoyl)-anthranilic acid (tranilast) against eruptive syringoma: report of two cases and review of published work","author":"Horie","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0985","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1346-8138.2010.01116.x","article-title":"Lupus miliaris disseminatus faciei successfully treated with tranilast: report of two cases","volume":"38","author":"Koike","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib0990","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1248\/bpb.27.1451","article-title":"Preventive effect of tranilast on oleic acid-induced lung injury in guinea pigs","volume":"27","author":"Ishitsuka","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.phrs.2014.10.009_bib0995","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2006.115469","article-title":"Long-term prospective pilot study with tranilast for the prevention of stricture progression in patients with Crohn's disease","volume":"56","author":"Oshitani","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2014.10.009_bib1000","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1016\/j.jaad.2005.02.013","article-title":"Annular elastolytic giant cell granuloma in an infant: improvement after treatment with oral tranilast and topical pimecrolimus","volume":"53","author":"Lee","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib1005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaad.2009.04.035","article-title":"Refractory cutaneous lichenoid sarcoidosis treated with tranilast","volume":"63","author":"Nakahigashi","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.phrs.2014.10.009_bib1010","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bmt.2009.173","article-title":"Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD","volume":"45","author":"Ogawa","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.phrs.2014.10.009_bib1015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1346-8138.1996.tb04026.x","article-title":"Solitary mastocytoma treated with tranilast","volume":"23","author":"Katoh","year":"1996","journal-title":"J Dermatol"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661814001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661814001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T12:32:00Z","timestamp":1747139520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661814001704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":201,"alternative-id":["S1043661814001704"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2014.10.009","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tranilast: A review of its therapeutic applications","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2014.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}